Hanyang University
↗Seoul, South Korea
Hanyang University is a leading private research university in South Korea, renowned for its strong emphasis on engineering and its 'Education-Research-Industry Cluster' (ERICA) model. The university operates a comprehensive medical and biotechnological ecosystem through the Hanyang University Medical Center (HYUMC) and the Hanyang Institute of Bioscience and Biotechnology (HY-IBB), focusing on translational research and technology commercialization.
The university is a pioneer in industry-academia collaboration, maintaining a robust pipeline of therapeutic candidates and medical technologies. Its research strengths lie in stem cell therapy, gene therapy, and immunology, particularly through specialized centers like the Hanyang University Hospital for Rheumatic Diseases. Hanyang consistently ranks among the top institutions in South Korea for technology transfer revenue and patent registrations, actively spinning off biotech startups through its technology holding company, HYU Holdings.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Academic Research & Translational Medicine
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$1M-$10M
Founded:1939
Ownership:nonprofit
Status:operating
FUNDING
Investors:Ministry of Science and ICT (South Korea), Ministry of Health and Welfare (South Korea), National Research Foundation of Korea
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2a
Modalities:Cell therapy, Gene therapy, Small molecule, Peptides, Nanoparticles, Digital Health
Active Trials:45
Trial Phases:Phase 1: 12 | Phase 2: 18 | Phase 3: 10 | Phase 4: 5
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Hanyang University Medical Center, HYU Holdings Co., Ltd., HYU ERICA Holdings Co., Ltd., HanBiotech Co., Ltd.
Key Partnerships:Bioplus Co., Ltd. (Strategic partnership for advanced bio and healthcare), MDimune (BioDrone platform collaboration), LG Chem (Secondary battery and bio-related tech transfer), Novartis (Clinical trial collaboration), Genentech (Clinical trial collaboration)
COMPETITION
Position:Leader
Competitors:Seoul National University, KAIST, Yonsei University, Sungkyunkwan University
LEADERSHIP
Key Executives:
Lee Ki-jeong - President of Hanyang University
Yoon Ho-joo - President of Hanyang University Medical Center
Bae Sang-cheol - Director of Hanyang Institute of Bioscience and Biotechnology
Scientific Founders:Kim Lyun-joon (Founder)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Hanyang University. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.